-
1
-
-
65249184946
-
Current concepts in Alzheimer's disease: A multidisciplinary review
-
Minati L, Edginton T, Bruzzone MG, Giaccone G: Current concepts in Alzheimer's disease: a multidisciplinary review. Am. J. Alzheimers Dis. Other Demen. 24(2), 95-121 (2009).
-
(2009)
Am. J. Alzheimers Dis. Other Demen
, vol.24
, Issue.2
, pp. 95-121
-
-
Minati, L.1
Edginton, T.2
Bruzzone, M.G.3
Giaccone, G.4
-
3
-
-
62149099593
-
Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review
-
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V: Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 8(4), 355-369 (2009).
-
(2009)
Lancet Neurol
, vol.8
, Issue.4
, pp. 355-369
-
-
Feigin, V.L.1
Lawes, C.M.2
Bennett, D.A.3
Barker-Collo, S.L.4
Parag, V.5
-
5
-
-
33744490350
-
Epidemiology and natural history of multiple sclerosis: New insights
-
Kantarci O, Wingerchuk D: Epidemiology and natural history of multiple sclerosis: new insights; Curr. Opin. Neurol. 19(3), 248-254 (2006).
-
(2006)
Curr. Opin. Neurol
, vol.19
, Issue.3
, pp. 248-254
-
-
Kantarci, O.1
Wingerchuk, D.2
-
6
-
-
33748966989
-
Epidemiology of neuroimmunological diseases
-
Flachenecker P: Epidemiology of neuroimmunological diseases. J. Neurol. 253(Suppl. 5), V2-V8 (2006).
-
(2006)
J. Neurol
, vol.253
, Issue.SUPPL. 5
-
-
Flachenecker, P.1
-
7
-
-
0041856595
-
Epidemiology of neurodegeneration
-
Mayeux R: Epidemiology of neurodegeneration. Annu. Rev. Neurosci. 26, 81-104 (2003).
-
(2003)
Annu. Rev. Neurosci
, vol.26
, pp. 81-104
-
-
Mayeux, R.1
-
8
-
-
33646234244
-
Approaches to palliative therapies for Alzheimer's disease
-
Robichaud AJ: Approaches to palliative therapies for Alzheimer's disease. Curr. Top. Med. Chem. 6(6), 553-568 (2006).
-
(2006)
Curr. Top. Med. Chem
, vol.6
, Issue.6
, pp. 553-568
-
-
Robichaud, A.J.1
-
9
-
-
34248350692
-
Palliative care in a myotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis
-
Elman LB, Houghton DJ, Wu GF, Hurtig HI, Markowitz CE, McCluskey L: Palliative care in a myotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. J. Palliat. Med. 10(2), 433-457 (2007).
-
(2007)
J. Palliat. Med
, vol.10
, Issue.2
, pp. 433-457
-
-
Elman, L.B.1
Houghton, D.J.2
Wu, G.F.3
Hurtig, H.I.4
Markowitz, C.E.5
McCluskey, L.6
-
10
-
-
13844297792
-
Parkinson's disease: From causes to mechanisms
-
Corti O, Hampe C, Darios F, Ibanez P, Ruberg M, Brice A: Parkinson's disease: from causes to mechanisms. C. R. Biol. 328(2), 131-142 (2005).
-
(2005)
C. R. Biol
, vol.328
, Issue.2
, pp. 131-142
-
-
Corti, O.1
Hampe, C.2
Darios, F.3
Ibanez, P.4
Ruberg, M.5
Brice, A.6
-
11
-
-
63849213978
-
Amyloid β-peptide aggregation. What does it result in and how can it be prevented?
-
Nerelius C, Johansson J, Sandegren A: Amyloid β-peptide aggregation. What does it result in and how can it be prevented? Front. Biosci. 14, 1716-1729 (2009).
-
(2009)
Front. Biosci
, vol.14
, pp. 1716-1729
-
-
Nerelius, C.1
Johansson, J.2
Sandegren, A.3
-
12
-
-
29044443820
-
Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease
-
Watson D, Castano E, Kokjohn TA et al.: Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease. Neurol. Res. 27(8), 869-881 (2005).
-
(2005)
Neurol. Res
, vol.27
, Issue.8
, pp. 869-881
-
-
Watson, D.1
Castano, E.2
Kokjohn, T.A.3
-
13
-
-
66049147738
-
The complexity of neurobiological processes in acute ischemic stroke
-
Brouns R, De Deyn PP: The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 111(6), 483-495 (2009).
-
(2009)
Clin. Neurol. Neurosurg
, vol.111
, Issue.6
, pp. 483-495
-
-
Brouns, R.1
De Deyn, P.P.2
-
16
-
-
33645046630
-
Potential therapeutic targets in the NF-κB pathway for Alzheimer's disease
-
Collister KA, Albensi BC: Potential therapeutic targets in the NF-κB pathway for Alzheimer's disease. Drug News Perspect. 18(10), 623-629 (2005).
-
(2005)
Drug News Perspect
, vol.18
, Issue.10
, pp. 623-629
-
-
Collister, K.A.1
Albensi, B.C.2
-
17
-
-
33645867989
-
Therapeutic targets for amyotrophic lateral sclerosis: Current treatments and prospects for more-effective therapies
-
Bruijn LI, Cudkowicz M: Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more-effective therapies. Expert Rev. Neurother. 6(3), 417-428 (2006).
-
(2006)
Expert Rev. Neurother
, vol.6
, Issue.3
, pp. 417-428
-
-
Bruijn, L.I.1
Cudkowicz, M.2
-
18
-
-
33646555181
-
CNS gene therapy and a nexus of complexity: Systems and biology at a crossroads
-
Tyler CM, Federoff HJ: CNS gene therapy and a nexus of complexity: systems and biology at a crossroads. Cell Transplant. 15(3), 267-273 (2006).
-
(2006)
Cell Transplant
, vol.15
, Issue.3
, pp. 267-273
-
-
Tyler, C.M.1
Federoff, H.J.2
-
19
-
-
67349195578
-
Early identification and treatment of Alzheimer's disease: Social and fiscal outcomes
-
Weimer DL, Sager MA: Early identification and treatment of Alzheimer's disease: social and fiscal outcomes. Alzheimers Dement. 5(3), 215-226 (2009).
-
(2009)
Alzheimers Dement
, vol.5
, Issue.3
, pp. 215-226
-
-
Weimer, D.L.1
Sager, M.A.2
-
20
-
-
67749118071
-
-
Querbes O, Aubry F, Pariente J et al.: Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain (2009).
-
Querbes O, Aubry F, Pariente J et al.: Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain (2009).
-
-
-
-
21
-
-
67651152993
-
Neuropsychological patterns in magnetic resonance imaging-defined subgroups of patients with degenerative dementia
-
Listerud J, Powers C, Moore P, Libon DJ, Grossman M: Neuropsychological patterns in magnetic resonance imaging-defined subgroups of patients with degenerative dementia. J. Int. Neuropsychol Soc. 15(3), 459-470 (2009).
-
(2009)
J. Int. Neuropsychol Soc
, vol.15
, Issue.3
, pp. 459-470
-
-
Listerud, J.1
Powers, C.2
Moore, P.3
Libon, D.J.4
Grossman, M.5
-
23
-
-
44049088526
-
Frontotemporal dementia: A review]
-
Chauvire V, Even C, Thuile J, Rouillon F, Guelfi JD: [Frontotemporal dementia: a review]. Encephale 33(6), 933-940 (2007).
-
(2007)
Encephale
, vol.33
, Issue.6
, pp. 933-940
-
-
Chauvire, V.1
Even, C.2
Thuile, J.3
Rouillon, F.4
Guelfi, J.D.5
-
24
-
-
32944472598
-
Frontotemporal dementia - Part II. Differential diagnosis, genetics, molecular pathomechanism and pathology
-
Galariotis V, Bodi N, Janka Z, Kalman J: Frontotemporal dementia - Part II. Differential diagnosis, genetics, molecular pathomechanism and pathology. Ideggyogy. Sz. 58(7-8), 220-224 (2005).
-
(2005)
Ideggyogy. Sz
, vol.58
, Issue.7-8
, pp. 220-224
-
-
Galariotis, V.1
Bodi, N.2
Janka, Z.3
Kalman, J.4
-
25
-
-
33751245916
-
Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: The Geneva experience
-
Giannakopoulos P, Gold G, Kovari E et al.: Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathol. 113(1), 1-12 (2007).
-
(2007)
Acta Neuropathol
, vol.113
, Issue.1
, pp. 1-12
-
-
Giannakopoulos, P.1
Gold, G.2
Kovari, E.3
-
26
-
-
65349171063
-
Pathological substrates of cognitive decline in Alzheimer's disease
-
Giannakopoulos P, Kovari E, Gold G, von Gunten A, Hof PR, Bouras C: Pathological substrates of cognitive decline in Alzheimer's disease. Front. Neurol. Neurosci. 24, 20-29 (2009).
-
(2009)
Front. Neurol. Neurosci
, vol.24
, pp. 20-29
-
-
Giannakopoulos, P.1
Kovari, E.2
Gold, G.3
von Gunten, A.4
Hof, P.R.5
Bouras, C.6
-
27
-
-
63449094460
-
Molecular pathogenesis of Alzheimer's disease: Reductionist versus expansionist approaches
-
Castellani RJ, Zhu X, Lee HG, Smith MA, Perry G: Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches. Int. J. Mol. Sci. 10(3), 1386-1406 (2009).
-
(2009)
Int. J. Mol. Sci
, vol.10
, Issue.3
, pp. 1386-1406
-
-
Castellani, R.J.1
Zhu, X.2
Lee, H.G.3
Smith, M.A.4
Perry, G.5
-
28
-
-
40749160944
-
Disease-modifying therapies in Alzheimer's disease
-
Salloway S, Mintzer J, Weiner MF, Cummings JL: Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement. 4(2), 65-79 (2008).
-
(2008)
Alzheimers Dement
, vol.4
, Issue.2
, pp. 65-79
-
-
Salloway, S.1
Mintzer, J.2
Weiner, M.F.3
Cummings, J.L.4
-
29
-
-
61849185913
-
Recent developments in Alzheimer's disease therapeutics
-
Rafii MS, Aisen PS: Recent developments in Alzheimer's disease therapeutics. BMC Med. 7, 7 (2009).
-
(2009)
BMC Med
, vol.7
, pp. 7
-
-
Rafii, M.S.1
Aisen, P.S.2
-
30
-
-
33750082029
-
Disease modifying therapy for AD?
-
Golde TE: Disease modifying therapy for AD? J. Neurochem. 99(3), 689-707 (2006).
-
(2006)
J. Neurochem
, vol.99
, Issue.3
, pp. 689-707
-
-
Golde, T.E.1
-
31
-
-
54249156984
-
Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies
-
Sigurdsson EM: Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies. J. Alzheimer Dis. 15(2), 157-168 (2008).
-
(2008)
J. Alzheimer Dis
, vol.15
, Issue.2
, pp. 157-168
-
-
Sigurdsson, E.M.1
-
32
-
-
59149107151
-
Neurotrophic support and oxidative stress: Converging effects in the normal and diseased nervous system
-
Gardiner J, Barton D, Overall R, Marc J: Neurotrophic support and oxidative stress: converging effects in the normal and diseased nervous system. Neuroscientist 15(1), 47-61 (2009).
-
(2009)
Neuroscientist
, vol.15
, Issue.1
, pp. 47-61
-
-
Gardiner, J.1
Barton, D.2
Overall, R.3
Marc, J.4
-
33
-
-
57449110125
-
NADPH oxidase as a therapeutic target in Alzheimer's disease
-
S
-
Block ML: NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci. 9(Suppl. 2), S8 (2008).
-
(2008)
BMC Neurosci
, vol.9
, Issue.SUPPL. 2
, pp. 8
-
-
Block, M.L.1
-
34
-
-
36549083642
-
Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer's disease
-
Rojo LE, Fernandez JA, Maccioni AA, Jimenez JM, Maccioni RB: Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch. Med. Res. 39(1), 1-16 (2008).
-
(2008)
Arch. Med. Res
, vol.39
, Issue.1
, pp. 1-16
-
-
Rojo, L.E.1
Fernandez, J.A.2
Maccioni, A.A.3
Jimenez, J.M.4
Maccioni, R.B.5
-
35
-
-
44849092655
-
Nanotechnology solutions for Alzheimer's disease: Advances in research tools, diagnostic methods and therapeutic agents
-
Nazem A, Mansoori GA: Nanotechnology solutions for Alzheimer's disease: advances in research tools, diagnostic methods and therapeutic agents. J. Alzheimers Dis. 13(2), 199-223 (2008).
-
(2008)
J. Alzheimers Dis
, vol.13
, Issue.2
, pp. 199-223
-
-
Nazem, A.1
Mansoori, G.A.2
-
36
-
-
0032507975
-
Copper, iron and zinc in Alzheimer's disease senile plaques
-
Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR: Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158(1), 47-52 (1998).
-
(1998)
J. Neurol. Sci
, vol.158
, Issue.1
, pp. 47-52
-
-
Lovell, M.A.1
Robertson, J.D.2
Teesdale, W.J.3
Campbell, J.L.4
Markesbery, W.R.5
-
37
-
-
0033964859
-
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals
-
Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA: In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J. Neurochem. 74(1), 270-279 (2000).
-
(2000)
J. Neurochem
, vol.74
, Issue.1
, pp. 270-279
-
-
Sayre, L.M.1
Perry, G.2
Harris, P.L.3
Liu, Y.4
Schubert, K.A.5
Smith, M.A.6
-
39
-
-
0027980901
-
Rapid induction of Alzheimer Aβ amyloid formation by zinc
-
Bush AI, Pettingell WH, Multhaup G et al.: Rapid induction of Alzheimer Aβ amyloid formation by zinc. Science 265(5177), 1464-1467 (1994).
-
(1994)
Science
, vol.265
, Issue.5177
, pp. 1464-1467
-
-
Bush, A.I.1
Pettingell, W.H.2
Multhaup, G.3
-
40
-
-
0028177269
-
The βA4 amyloid precursor protein binding to copper
-
Hesse L, Beher D, Masters CL, Multhaup G: The βA4 amyloid precursor protein binding to copper. FEBS Lett. 349(1), 109-116 (1994).
-
(1994)
FEBS Lett
, vol.349
, Issue.1
, pp. 109-116
-
-
Hesse, L.1
Beher, D.2
Masters, C.L.3
Multhaup, G.4
-
41
-
-
0028031808
-
Effects of chelators on iron uptake and release by the brain in the rat
-
Crowe A, Morgan EH: Effects of chelators on iron uptake and release by the brain in the rat. Neurochem. Res. 19(1), 71-76 (1994).
-
(1994)
Neurochem. Res
, vol.19
, Issue.1
, pp. 71-76
-
-
Crowe, A.1
Morgan, E.H.2
-
42
-
-
0027943274
-
Iron chelator design
-
Hider RC, Epemolu O, Singh S, Porter JB: Iron chelator design. Adv. Exp. Med. Biol. 356, 343-349 (1994).
-
(1994)
Adv. Exp. Med. Biol
, vol.356
, pp. 343-349
-
-
Hider, R.C.1
Epemolu, O.2
Singh, S.3
Porter, J.B.4
-
43
-
-
34548406555
-
Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis
-
Marsh JN, Senpan A, Hu G et al.: Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomed. 2(4), 533-543 (2007).
-
(2007)
Nanomed
, vol.2
, Issue.4
, pp. 533-543
-
-
Marsh, J.N.1
Senpan, A.2
Hu, G.3
-
44
-
-
12344251715
-
Novel D- penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases
-
Cui Z, Lockman PR, Atwbood CS et al.: Novel D- penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases. Eur. J. Pharm. Biopharm. 59(2), 263-272 (2005).
-
(2005)
Eur. J. Pharm. Biopharm
, vol.59
, Issue.2
, pp. 263-272
-
-
Cui, Z.1
Lockman, P.R.2
Atwbood, C.S.3
-
45
-
-
33748202940
-
Nanoparticle iron chelators: A new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance
-
Liu G, Men P, Harris PL, Rolston RK, Perry G, Smith MA: Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neurosci. Lett. 406(3), 189-193 (2006).
-
(2006)
Neurosci. Lett
, vol.406
, Issue.3
, pp. 189-193
-
-
Liu, G.1
Men, P.2
Harris, P.L.3
Rolston, R.K.4
Perry, G.5
Smith, M.A.6
-
46
-
-
64049104164
-
Nanoparticle - chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease
-
Liu G, Men P, Kudo W, Perry G, Smith MA: Nanoparticle - chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease. Neurosci. Lett. 455(3), 187-190 (2009).
-
(2009)
Neurosci. Lett
, vol.455
, Issue.3
, pp. 187-190
-
-
Liu, G.1
Men, P.2
Kudo, W.3
Perry, G.4
Smith, M.A.5
-
47
-
-
10744226316
-
Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice
-
Bayer TA, Schafer S, Simons A et al.: Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. Proc. Natl Acad. Sci. USA 100(24), 14187-14192 (2003).
-
(2003)
Proc. Natl Acad. Sci. USA
, vol.100
, Issue.24
, pp. 14187-14192
-
-
Bayer, T.A.1
Schafer, S.2
Simons, A.3
-
48
-
-
2442586535
-
Copper depletion down-regulates expression of the Alzheimer's disease amyloid-β precursor protein gene
-
Bellingham SA, Lahiri DK, Maloney B, La Fontaine S, Multhaup G, Camakaris J: Copper depletion down-regulates expression of the Alzheimer's disease amyloid-β precursor protein gene. J. Biol. Chem. 279(19), 20378-20386 (2004).
-
(2004)
J. Biol. Chem
, vol.279
, Issue.19
, pp. 20378-20386
-
-
Bellingham, S.A.1
Lahiri, D.K.2
Maloney, B.3
La Fontaine, S.4
Multhaup, G.5
Camakaris, J.6
-
49
-
-
10744228112
-
In vivo reduction of amyloid-β by a mutant copper transporter
-
Phinney AL, Drisaldi B, Schmidt SD et al.: In vivo reduction of amyloid-β by a mutant copper transporter. Proc. Natl Acad. Sci. USA 100(24), 14193-14198 (2003).
-
(2003)
Proc. Natl Acad. Sci. USA
, vol.100
, Issue.24
, pp. 14193-14198
-
-
Phinney, A.L.1
Drisaldi, B.2
Schmidt, S.D.3
-
50
-
-
66149175672
-
Cellular copper import by nanocarrier systems, intracellular availability and effects on amyloid peptide secretion
-
Multhaup G, Treiber C, Quadir M et al.: Cellular copper import by nanocarrier systems, intracellular availability and effects on amyloid peptide secretion. Biochemistry 48(20), 4273-4284 (2009).
-
(2009)
Biochemistry
, vol.48
, Issue.20
, pp. 4273-4284
-
-
Multhaup, G.1
Treiber, C.2
Quadir, M.3
-
51
-
-
49749092065
-
Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: A pilot Phase 2 clinical trial
-
Kessler H, Bayer TA, Bach D et al.: Intake of copper has no effect on cognition in patients with mild Alzheimer's disease: a pilot Phase 2 clinical trial. J. Neural Transm. 115(8), 1181-1187 (2008).
-
(2008)
J. Neural Transm
, vol.115
, Issue.8
, pp. 1181-1187
-
-
Kessler, H.1
Bayer, T.A.2
Bach, D.3
-
52
-
-
46149107512
-
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ
-
Adlard PA, Cherny RA, Finkelstein DI et al.: Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ. Neuron 59(1), 43-55 (2008).
-
(2008)
Neuron
, vol.59
, Issue.1
, pp. 43-55
-
-
Adlard, P.A.1
Cherny, R.A.2
Finkelstein, D.I.3
-
53
-
-
34249686578
-
Pro-apoptotic activity of novel isatin-Schiff base copper(II) complexes depends on oxidative stress induction and organelle-selective damage
-
Filomeni G, Cerchiaro G, Da Costa Ferreira AM et al.: Pro-apoptotic activity of novel isatin-Schiff base copper(II) complexes depends on oxidative stress induction and organelle-selective damage. J. Biol. Chem. 282(16), 12010-12021 (2007).
-
(2007)
J. Biol. Chem
, vol.282
, Issue.16
, pp. 12010-12021
-
-
Filomeni, G.1
Cerchiaro, G.2
Da Costa Ferreira, A.M.3
-
54
-
-
4644238758
-
The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice
-
Lee JY, Friedman JE, Angel I, Kozak A, Koh JY: The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice. Neurobiol. Aging 25(10), 1315-1321 (2004).
-
(2004)
Neurobiol. Aging
, vol.25
, Issue.10
, pp. 1315-1321
-
-
Lee, J.Y.1
Friedman, J.E.2
Angel, I.3
Kozak, A.4
Koh, J.Y.5
-
55
-
-
67349139416
-
Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid
-
Strozyk D, Launer LJ, Adlard PA et al.: Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid. Neurobiol. Aging 30(7), 1069-1077 (2007).
-
(2007)
Neurobiol. Aging
, vol.30
, Issue.7
, pp. 1069-1077
-
-
Strozyk, D.1
Launer, L.J.2
Adlard, P.A.3
-
56
-
-
36749044742
-
Zinc binding to amyloid-β: Isothermal titration calorimetry and Zn competition experiments with Zn sensors
-
Talmard C, Bouzan A, Faller P: Zinc binding to amyloid-β: isothermal titration calorimetry and Zn competition experiments with Zn sensors. Biochemistry 46(47), 13658-13666 (2007).
-
(2007)
Biochemistry
, vol.46
, Issue.47
, pp. 13658-13666
-
-
Talmard, C.1
Bouzan, A.2
Faller, P.3
-
57
-
-
51749106579
-
Abundant expression of zinc transporters in the amyloid, plaques of Alzheimer's disease brain
-
Zhang LH, Wang X, Stoltenberg M, Danscher G, Huang L, Wang ZY: Abundant expression of zinc transporters in the amyloid, plaques of Alzheimer's disease brain. Brain Res. Bull. 77(1), 55-60 (2008).
-
(2008)
Brain Res. Bull
, vol.77
, Issue.1
, pp. 55-60
-
-
Zhang, L.H.1
Wang, X.2
Stoltenberg, M.3
Danscher, G.4
Huang, L.5
Wang, Z.Y.6
-
58
-
-
34548130742
-
EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases
-
Klajnert B, Cangiotti M, Calici S et al.: EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and prion diseases. Macromol. Biosci. 7(8), 1065-1074 (2007).
-
(2007)
Macromol. Biosci
, vol.7
, Issue.8
, pp. 1065-1074
-
-
Klajnert, B.1
Cangiotti, M.2
Calici, S.3
-
59
-
-
56449124781
-
Inhibition of amyloid β protein fibrillation by polymeric nanoparticles
-
Cabaleiro-Lago C, Quinlan-Pluck F, Lynch I et al.: Inhibition of amyloid β protein fibrillation by polymeric nanoparticles. J. Am. Chem. Soc. 130(46), 15437-15443 (2008).
-
(2008)
J. Am. Chem. Soc
, vol.130
, Issue.46
, pp. 15437-15443
-
-
Cabaleiro-Lago, C.1
Quinlan-Pluck, F.2
Lynch, I.3
-
60
-
-
34447517643
-
60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task
-
60 fullerene on amyloid 1-peptide fibrillization in vitro and performance of the cognitive task. J. Nanosci. Nanotechnol. 7(4-5), 1479-1485 (2007).
-
(2007)
J. Nanosci. Nanotechnol
, vol.7
, Issue.4-5
, pp. 1479-1485
-
-
Podolski, I.Y.1
Podlubnaya, Z.A.2
Kosenko, E.A.3
-
61
-
-
33750052628
-
PEGylated phospholipid nanomicelles interact with β-amyloid(1-42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro
-
Pai AS, Rubinstein I, Onyuksel H: PEGylated phospholipid nanomicelles interact with β-amyloid(1-42) and mitigate its β-sheet formation, aggregation and neurotoxicity in vitro. Peptides 27(11), 2858-2866 (2006).
-
(2006)
Peptides
, vol.27
, Issue.11
, pp. 2858-2866
-
-
Pai, A.S.1
Rubinstein, I.2
Onyuksel, H.3
-
62
-
-
67650431678
-
Effect of maghemite nanoparticles on insulin amyloid fibril formation: Selective labeling, kinetics, and fibril removal by a magnetic field
-
Skaat H, Sorci M, Belfort G, Margel S: Effect of maghemite nanoparticles on insulin amyloid fibril formation: selective labeling, kinetics, and fibril removal by a magnetic field. J. Biomed. Mater. Res. A (2008).
-
(2008)
J. Biomed. Mater. Res. A
-
-
Skaat, H.1
Sorci, M.2
Belfort, G.3
Margel, S.4
-
63
-
-
34447513070
-
Attenuation of β-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: Role of sialic acid attachment
-
Patel DA, Henry JE, Good TA: Attenuation of β-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: role of sialic acid attachment. Brain Res. 1161, 95-105 (2007).
-
(2007)
Brain Res
, vol.1161
, pp. 95-105
-
-
Patel, D.A.1
Henry, J.E.2
Good, T.A.3
-
64
-
-
33750626825
-
Attenuation of β-amyloid induced toxicity by sialic acid-conjugated dendrimeric polymers
-
Patel D, Henry J, Good T: Attenuation of β-amyloid induced toxicity by sialic acid-conjugated dendrimeric polymers. Biochim. Biophys. Acta 1760(12), 1802-1809 (2006).
-
(2006)
Biochim. Biophys. Acta
, vol.1760
, Issue.12
, pp. 1802-1809
-
-
Patel, D.1
Henry, J.2
Good, T.3
-
65
-
-
45749115053
-
How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for β-amyloid fibrils
-
Olmedo I, Araya E, Sanz F et al.: How changes in the sequence of the peptide CLPFFD-NH2 can modify the conjugation and stability of gold nanoparticles and their affinity for β-amyloid fibrils. Bioconjug. Chem. 19(6), 1154-1163 (2008).
-
(2008)
Bioconjug. Chem
, vol.19
, Issue.6
, pp. 1154-1163
-
-
Olmedo, I.1
Araya, E.2
Sanz, F.3
-
66
-
-
42049091686
-
Photothermal ablation of amyloid aggregates by gold nanoparticles
-
Triulzi RC, Dai Q, Zou J et al.: Photothermal ablation of amyloid aggregates by gold nanoparticles. Colloids Surf. B Biointerfaces 63(2), 200-208 (2008).
-
(2008)
Colloids Surf. B Biointerfaces
, vol.63
, Issue.2
, pp. 200-208
-
-
Triulzi, R.C.1
Dai, Q.2
Zou, J.3
-
67
-
-
31544459915
-
Nanoparticle-mediated local and remote manipulation of protein aggregation
-
Kogan MJ, Bastus NG, Amigo R et al.: Nanoparticle-mediated local and remote manipulation of protein aggregation. Nano Lett. 6(1), 110-115 (2006).
-
(2006)
Nano Lett
, vol.6
, Issue.1
, pp. 110-115
-
-
Kogan, M.J.1
Bastus, N.G.2
Amigo, R.3
-
68
-
-
58149374037
-
Antioxidant therapy in Alzheimer's disease: Theory and practice
-
Aliev G, Obrenovich ME, Reddy VP et al.: Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev. Med. Chem. 8(13), 1395-1406 (2008).
-
(2008)
Mini Rev. Med. Chem
, vol.8
, Issue.13
, pp. 1395-1406
-
-
Aliev, G.1
Obrenovich, M.E.2
Reddy, V.P.3
-
69
-
-
55649106830
-
Targeting, reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease
-
Yokoyama H, Kuroiwa H, Yano R, Araki T: Targeting, reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease. Neurol. Sci. 29(5), 293-301 (2008).
-
(2008)
Neurol. Sci
, vol.29
, Issue.5
, pp. 293-301
-
-
Yokoyama, H.1
Kuroiwa, H.2
Yano, R.3
Araki, T.4
-
70
-
-
44949242548
-
Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice
-
Yokoyama H, Takagi S, Watanabe Y, Kato H, Araki T: Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice. J. Neural Transm. 115(6), 831-842 (2008).
-
(2008)
J. Neural Transm
, vol.115
, Issue.6
, pp. 831-842
-
-
Yokoyama, H.1
Takagi, S.2
Watanabe, Y.3
Kato, H.4
Araki, T.5
-
71
-
-
58149498314
-
Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer's disease
-
Wilson B, Samanta MK, Santhi K, Sampath Kumar KP, Ramasamy M, Suresh B: Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer's disease. J. Neurosci. Methods 177(2), 427-433 (2009).
-
(2009)
J. Neurosci. Methods
, vol.177
, Issue.2
, pp. 427-433
-
-
Wilson, B.1
Samanta, M.K.2
Santhi, K.3
Sampath Kumar, K.P.4
Ramasamy, M.5
Suresh, B.6
-
72
-
-
34147092491
-
Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: In vitro and in vivo studies and the application in the treatment of the impaired memory of mice
-
Chu D, Tian J, Liu W, Li Z, Li Y: Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice. Chem. Pharm. Bull. (Tokyo) 55(4), 625-628 (2007).
-
(2007)
Chem. Pharm. Bull. (Tokyo)
, vol.55
, Issue.4
, pp. 625-628
-
-
Chu, D.1
Tian, J.2
Liu, W.3
Li, Z.4
Li, Y.5
-
73
-
-
33847045172
-
Prolonged effects of poly(lactic-co-glycolic acid) microsphere-containing huperzine A on mouse memory dysfunction induced by scopolamine
-
Wang C, Zhang T, Ma H, Liu J, Fu F, Liu K: Prolonged effects of poly(lactic-co-glycolic acid) microsphere-containing huperzine A on mouse memory dysfunction induced by scopolamine. Basic Clin. Pharmacol. Toxicol. 100(3), 190-195 (2007).
-
(2007)
Basic Clin. Pharmacol. Toxicol
, vol.100
, Issue.3
, pp. 190-195
-
-
Wang, C.1
Zhang, T.2
Ma, H.3
Liu, J.4
Fu, F.5
Liu, K.6
-
75
-
-
67449110725
-
Electrical detection of β-amyloid (1-40) using scanning tunneling microscopy
-
Lee JH, Kang DY, Kim SU, Yea CH, Oh BK, Choi JW: Electrical detection of β-amyloid (1-40) using scanning tunneling microscopy. Ultramicroscopy (2009).
-
(2009)
Ultramicroscopy
-
-
Lee, J.H.1
Kang, D.Y.2
Kim, S.U.3
Yea, C.H.4
Oh, B.K.5
Choi, J.W.6
-
76
-
-
58149147452
-
Ultra-sensitive immunosensor for β-amyloid (1-42) using scanning tunneling microscopy-based electrical detection
-
Kang DY, Lee JH, Oh BK, Choi JW: Ultra-sensitive immunosensor for β-amyloid (1-42) using scanning tunneling microscopy-based electrical detection. Biosens. Bioelectron. 24(5), 1431-1436 (2009).
-
(2009)
Biosens. Bioelectron
, vol.24
, Issue.5
, pp. 1431-1436
-
-
Kang, D.Y.1
Lee, J.H.2
Oh, B.K.3
Choi, J.W.4
-
77
-
-
37449000878
-
Detection of Alzheimer's tail protein using localised surface plasmon resonance-based immunochip
-
Vestergaard M, Kerman K, Kim DK, Ha MH, Tamiya E: Detection of Alzheimer's tail protein using localised surface plasmon resonance-based immunochip. Talanta 74(4), 1038-1042 (2008).
-
(2008)
Talanta
, vol.74
, Issue.4
, pp. 1038-1042
-
-
Vestergaard, M.1
Kerman, K.2
Kim, D.K.3
Ha, M.H.4
Tamiya, E.5
-
78
-
-
57049182374
-
Neuroanatomy and pathology of sporadic Parkinson's disease
-
Braak H, Del Tredici K: Neuroanatomy and pathology of sporadic Parkinson's disease. Adv. Anat. Embryol. Cell Biol. 201, 1-119 (2009).
-
(2009)
Adv. Anat. Embryol. Cell Biol
, vol.201
, pp. 1-119
-
-
Braak, H.1
Del Tredici, K.2
-
79
-
-
0141741347
-
Parkinson's disease: Mechanisms and models
-
Dauer W, Przedborski S: Parkinson's disease: mechanisms and models. Neuron 39(6), 889-909 (2003).
-
(2003)
Neuron
, vol.39
, Issue.6
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
80
-
-
57649155208
-
Oxidative stress in Parkinson's disease: A mechanism of pathogenic and therapeutic significance
-
Zhou C, Huang Y, Przedborski S: Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann. NY Acad. Sci. 1147, 93-104 (2008).
-
(2008)
Ann. NY Acad. Sci
, vol.1147
, pp. 93-104
-
-
Zhou, C.1
Huang, Y.2
Przedborski, S.3
-
81
-
-
62549133546
-
Neuroinflammation in Parkinson's disease: A target for neuroprotection?
-
Hirsch EC, Hunot S: Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 8(4), 382-397 (2009).
-
(2009)
Lancet Neurol
, vol.8
, Issue.4
, pp. 382-397
-
-
Hirsch, E.C.1
Hunot, S.2
-
82
-
-
55249087467
-
Immunological features of α-synuclein in Parkinson's disease
-
2008
-
Roodveldt C, Christodoulou J, Dobson CM: Immunological features of α-synuclein in Parkinson's disease. J. Cell Mol. Med. 12(5B), 1820-1829 (2008).
-
(1820)
J. Cell Mol. Med
, Issue.5 B
, pp. 12
-
-
Roodveldt, C.1
Christodoulou, J.2
Dobson, C.M.3
-
83
-
-
63149090431
-
Parkinson's disease: From monogenic forms to genetic susceptibility factors
-
Lesage S, Brice A: Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 18(R1), R48-R59 (2009).
-
(2009)
Hum. Mol. Genet
, vol.18
, Issue.R1
-
-
Lesage, S.1
Brice, A.2
-
84
-
-
34447500085
-
Autonomic dysfunction in Parkinson's disease
-
Dubow JS: Autonomic dysfunction in Parkinson's disease. Dis. Mon. 53(5), 265-274 (2007).
-
(2007)
Dis. Mon
, vol.53
, Issue.5
, pp. 265-274
-
-
Dubow, J.S.1
-
85
-
-
17844365885
-
Symptoms of autonomic failure in Parkinson's disease: Prevalence and impact on daily life
-
Magerkurth C, Schnitzer R, Braune S: Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin. Auton. Res. 15(2), 76-82 (2005).
-
(2005)
Clin. Auton. Res
, vol.15
, Issue.2
, pp. 76-82
-
-
Magerkurth, C.1
Schnitzer, R.2
Braune, S.3
-
87
-
-
33845211714
-
Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease
-
Mosley RL, Benner EJ, Kadiu I et al.: Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease. Clin. Neurosci. Res. 6(5), 261-281 (2006).
-
(2006)
Clin. Neurosci. Res
, vol.6
, Issue.5
, pp. 261-281
-
-
Mosley, R.L.1
Benner, E.J.2
Kadiu, I.3
-
91
-
-
36048975129
-
Fullerenes: Multitask components in molecular machinery
-
Mateo-Alonso A, Guldi DM, Paolucci F, Prato M: Fullerenes: multitask components in molecular machinery. Angew. Chem. Int. Ed. Engl. 46(43), 8120-8126 (2007).
-
(2007)
Angew. Chem. Int. Ed. Engl
, vol.46
, Issue.43
, pp. 8120-8126
-
-
Mateo-Alonso, A.1
Guldi, D.M.2
Paolucci, F.3
Prato, M.4
-
92
-
-
34548572856
-
Fullerenes in biology]
-
Krokosz A: [Fullerenes in biology]. Postepy Biochem. 53(1), 91-96 (2007).
-
(2007)
Postepy Biochem
, vol.53
, Issue.1
, pp. 91-96
-
-
Krokosz, A.1
-
96
-
-
59349094291
-
+-induced cellular model of Parkinson's disease
-
+-induced cellular model of Parkinson's disease. J. Neurosci. Res. 86(16), 3622-3634 (2008).
-
(2008)
J. Neurosci. Res
, vol.86
, Issue.16
, pp. 3622-3634
-
-
Cai, X.1
Jia, H.2
Liu, Z.3
-
97
-
-
34547601983
-
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders
-
Kabanov AV, Gendelman HE: Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog. Polym. Sci. 32, 1054-1082 (2007).
-
(2007)
Prog. Polym. Sci
, vol.32
, pp. 1054-1082
-
-
Kabanov, A.V.1
Gendelman, H.E.2
-
98
-
-
34648843409
-
A macrophage - nanozyme delivery system for Parkinson's disease
-
Batrakova EV, Li S, Reynolds AD et al.: A macrophage - nanozyme delivery system for Parkinson's disease. Bioconjug. Chem. 18(5), 1498-1506 (2007).
-
(2007)
Bioconjug. Chem
, vol.18
, Issue.5
, pp. 1498-1506
-
-
Batrakova, E.V.1
Li, S.2
Reynolds, A.D.3
-
102
-
-
0242414731
-
Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns
-
Hashimoto M, Asai Y, Ogawa T: Treponemal phospholipids inhibit innate immune responses induced by pathogen-associated molecular patterns. J. Biol. Chem. 278(45), 44205-44213 (2003).
-
(2003)
J. Biol. Chem
, vol.278
, Issue.45
, pp. 44205-44213
-
-
Hashimoto, M.1
Asai, Y.2
Ogawa, T.3
-
103
-
-
0036143018
-
Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation
-
Huynh ML, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Invest. 109(1), 41-50 (2002).
-
(2002)
J. Clin. Invest
, vol.109
, Issue.1
, pp. 41-50
-
-
Huynh, M.L.1
Fadok, V.A.2
Henson, P.M.3
-
104
-
-
38349136184
-
Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease
-
Crotty S, Fitzgerald P, Tuohy E et al.: Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease. Eur. J. Neurosci. 27(2), 294-300 (2008).
-
(2008)
Eur. J. Neurosci
, vol.27
, Issue.2
, pp. 294-300
-
-
Crotty, S.1
Fitzgerald, P.2
Tuohy, E.3
-
105
-
-
68649118090
-
A critical evaluation of the ubiquitin - proteasome system in Parkinson's disease
-
Cook C, Petrucelli L: A critical evaluation of the ubiquitin - proteasome system in Parkinson's disease. Biochim. Biophys. Acta (2009).
-
(2009)
Biochim. Biophys. Acta
-
-
Cook, C.1
Petrucelli, L.2
-
106
-
-
54249153676
-
Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: Implications for Parkinson's disease
-
Fitzgerald P, Mandel A, Bolton AE, Sullivan AM, Nolan Y: Treatment with phosphotidylglycerol-based nanoparticles prevents motor deficits induced by proteasome inhibition: implications for Parkinson's disease. Behav. Brain Res. 195(2), 271-274 (2008).
-
(2008)
Behav. Brain Res
, vol.195
, Issue.2
, pp. 271-274
-
-
Fitzgerald, P.1
Mandel, A.2
Bolton, A.E.3
Sullivan, A.M.4
Nolan, Y.5
-
107
-
-
65449172441
-
Functional protein delivery into neurons using polymeric nanoparticles
-
Hasadsri L, Kreuter J, Hattori H, Iwasaki T, George JM: Functional protein delivery into neurons using polymeric nanoparticles. J. Biol. Chem. 284(11), 6972-6981 (2009).
-
(2009)
J. Biol. Chem
, vol.284
, Issue.11
, pp. 6972-6981
-
-
Hasadsri, L.1
Kreuter, J.2
Hattori, H.3
Iwasaki, T.4
George, J.M.5
-
108
-
-
44749092720
-
Solid lipid nanoparticles as delivery systems for bromocriptine
-
Esposito E, Fantin M, Marti M et al.: Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm. Res. 25(7), 1521-1530 (2008).
-
(2008)
Pharm. Res
, vol.25
, Issue.7
, pp. 1521-1530
-
-
Esposito, E.1
Fantin, M.2
Marti, M.3
-
109
-
-
33746493905
-
Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: A population-based study in southern Italy
-
Zoccolella S, Beghi E, Palagano G et al.: Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy. Eur. J. Neurol. 13(7), 789-792 (2006).
-
(2006)
Eur. J. Neurol
, vol.13
, Issue.7
, pp. 789-792
-
-
Zoccolella, S.1
Beghi, E.2
Palagano, G.3
-
110
-
-
34250209501
-
Amyotrophic lateral sclerosis
-
Mitchell JD, Borasio GD: Amyotrophic lateral sclerosis. Lancet 369(9578), 2031-2041 (2007).
-
(2007)
Lancet
, vol.369
, Issue.9578
, pp. 2031-2041
-
-
Mitchell, J.D.1
Borasio, G.D.2
-
111
-
-
33750457344
-
Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)
-
Qureshi MM, Hayden D, Urbinelli L et al.: Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph. Lateral Scler. 7(3), 173-182 (2006).
-
(2006)
Amyotroph. Lateral Scler
, vol.7
, Issue.3
, pp. 173-182
-
-
Qureshi, M.M.1
Hayden, D.2
Urbinelli, L.3
-
112
-
-
23144448320
-
Molecular and cellular pathways of neurodegeneration in motor neurone disease
-
Shaw PJ: Molecular and cellular pathways of neurodegeneration in motor neurone disease. J. Neurol. Neurosurg. Psychiatry 76(8), 1046-1057 (2005).
-
(2005)
J. Neurol. Neurosurg. Psychiatry
, vol.76
, Issue.8
, pp. 1046-1057
-
-
Shaw, P.J.1
-
113
-
-
60849093466
-
Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
-
Rothstein JD: Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65(Suppl. 1), S3-S9 (2009).
-
(2009)
Ann. Neurol
, vol.65
, Issue.SUPPL. 1
-
-
Rothstein, J.D.1
-
114
-
-
61449097436
-
Amyotrophic lateral sclerosis: A 40-year personal perspective
-
Eisen A: Amyotrophic lateral sclerosis: a 40-year personal perspective. J. Clin. Neurosci. 16(4), 505-512 (2009).
-
(2009)
J. Clin. Neurosci
, vol.16
, Issue.4
, pp. 505-512
-
-
Eisen, A.1
-
115
-
-
58149202714
-
Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress
-
Reddy MK, Wu L, Kou W, Ghorpade A, Labhasetwar V: Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress. Appl. Biochem. Biotechnol. 151(2-3), 565-577 (2008).
-
(2008)
Appl. Biochem. Biotechnol
, vol.151
, Issue.2-3
, pp. 565-577
-
-
Reddy, M.K.1
Wu, L.2
Kou, W.3
Ghorpade, A.4
Labhasetwar, V.5
-
116
-
-
55949103187
-
SOD activity of carboxyfullerenes predicts their neuroprotective efficacy: A structure - activity study
-
Ali SS, Hardt JI, Dugan LL: SOD activity of carboxyfullerenes predicts their neuroprotective efficacy: a structure - activity study. Nanomedicine 4(4), 283-294 (2008).
-
(2008)
Nanomedicine
, vol.4
, Issue.4
, pp. 283-294
-
-
Ali, S.S.1
Hardt, J.I.2
Dugan, L.L.3
-
117
-
-
0033947469
-
Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation
-
Shibata N, Nagai R, Miyata S et al.: Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol. 100(3), 275-284 (2000).
-
(2000)
Acta Neuropathol
, vol.100
, Issue.3
, pp. 275-284
-
-
Shibata, N.1
Nagai, R.2
Miyata, S.3
-
118
-
-
56549114614
-
Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death
-
Cho Y, Shi R, Borgens RB, Ivanisevic A: Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death. Nanomed. 3(4), 507-519 (2008).
-
(2008)
Nanomed
, vol.3
, Issue.4
, pp. 507-519
-
-
Cho, Y.1
Shi, R.2
Borgens, R.B.3
Ivanisevic, A.4
-
119
-
-
63649134784
-
Sensitive and colorimetric detection of the structural evolution of superoxide dismutase with gold nanoparticles
-
Hong S, Choi I, Lee S, Yang YI, Kang T, Yi J: Sensitive and colorimetric detection of the structural evolution of superoxide dismutase with gold nanoparticles. Anal. Chem. 81(4), 1378-1382 (2009).
-
(2009)
Anal. Chem
, vol.81
, Issue.4
, pp. 1378-1382
-
-
Hong, S.1
Choi, I.2
Lee, S.3
Yang, Y.I.4
Kang, T.5
Yi, J.6
-
120
-
-
63849212156
-
Cognition in multiple sclerosis: A review of neuropsychological and fMRI research
-
Genova HM, Sumowski JF, Chiaravalloti N, Voelbel GT, Deluca J: Cognition in multiple sclerosis: a review of neuropsychological and fMRI research. Front. Biosci. 14, 1730-1744 (2009).
-
(2009)
Front. Biosci
, vol.14
, pp. 1730-1744
-
-
Genova, H.M.1
Sumowski, J.F.2
Chiaravalloti, N.3
Voelbel, G.T.4
Deluca, J.5
-
121
-
-
33745312709
-
Cognitive. dysfunction in multiple sclerosis: Assessment, imaging, and risk factors
-
Wallin MT, Wilken JA, Kane R: Cognitive. dysfunction in multiple sclerosis: Assessment, imaging, and risk factors. J. Rehabil. Res. Dev. 43(1), 63-72 (2006).
-
(2006)
J. Rehabil. Res. Dev
, vol.43
, Issue.1
, pp. 63-72
-
-
Wallin, M.T.1
Wilken, J.A.2
Kane, R.3
-
122
-
-
13944266747
-
Prelude to the framing of a disease: Multiple sclerosis in the period before Charcots Lecons
-
Murray J: Prelude to the framing of a disease: multiple sclerosis in the period before Charcots Lecons. Int. MS J. 11(3), 79-85 (2004).
-
(2004)
Int. MS J
, vol.11
, Issue.3
, pp. 79-85
-
-
Murray, J.1
-
123
-
-
23844506444
-
Multiple sclerosis pathology: Evolution of pathogenetic concepts
-
Lassmann H: Multiple sclerosis pathology: evolution of pathogenetic concepts. Brain Pathol. 15(3), 217-222 (2005).
-
(2005)
Brain Pathol
, vol.15
, Issue.3
, pp. 217-222
-
-
Lassmann, H.1
-
124
-
-
0342906187
-
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
-
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47(6), 707-717 (2000).
-
(2000)
Ann. Neurol
, vol.47
, Issue.6
, pp. 707-717
-
-
Lucchinetti, C.1
Bruck, W.2
Parisi, J.3
Scheithauer, B.4
Rodriguez, M.5
Lassmann, H.6
-
125
-
-
64149103383
-
Pathophysiology of multiple sclerosis
-
Korn T: Pathophysiology of multiple sclerosis. J. Neurol. 255(Suppl. 6), (2008).
-
(2008)
J. Neurol
, vol.255
, Issue.SUPPL. 6
-
-
Korn, T.1
-
126
-
-
70249121764
-
-
Rojas JI, Romano M, Ciapponi A, Patrucco L, Cristiano E: Interfeon β for primary progressive multiple sclerosis. Cochrane Database Syst. Rev. 1, CD006643 (2009).
-
Rojas JI, Romano M, Ciapponi A, Patrucco L, Cristiano E: Interfeon β for primary progressive multiple sclerosis. Cochrane Database Syst. Rev. 1, CD006643 (2009).
-
-
-
-
127
-
-
44949141642
-
-
Clerico M, Faggiano F, Palace J, Rice G, Tintore M, Durelli L: Recombinant interferon β or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane Database Syst. Rev. 2, CD005278 (2008).
-
Clerico M, Faggiano F, Palace J, Rice G, Tintore M, Durelli L: Recombinant interferon β or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane Database Syst. Rev. 2, CD005278 (2008).
-
-
-
-
128
-
-
64149099359
-
Neuroprotection and neuroregeneration in multiple sclerosis
-
Stangel M: Neuroprotection and neuroregeneration in multiple sclerosis. J. Neurol. 255(Suppl. 6), 77-81 (2008).
-
(2008)
J. Neurol
, vol.255
, Issue.SUPPL. 6
, pp. 77-81
-
-
Stangel, M.1
-
129
-
-
34248657276
-
Remyelination in multiple sclerosis
-
Chari DM: Remyelination in multiple sclerosis. Int. Rev. Neurobiol. 79, 589-620 (2007).
-
(2007)
Int. Rev. Neurobiol
, vol.79
, pp. 589-620
-
-
Chari, D.M.1
-
130
-
-
54249124952
-
Remyelination in the CNS: From biology to therapy
-
Franklin RJ, Ffrench-Constant C: Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9(11), 839-855 (2008).
-
(2008)
Nat. Rev. Neurosci
, vol.9
, Issue.11
, pp. 839-855
-
-
Franklin, R.J.1
Ffrench-Constant, C.2
-
131
-
-
41849124231
-
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis
-
Basso AS, Frenkel D, Quintana FJ et al.: Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. J. Clin. Invest. 118(4), 1532-1543 (2008).
-
(2008)
J. Clin. Invest
, vol.118
, Issue.4
, pp. 1532-1543
-
-
Basso, A.S.1
Frenkel, D.2
Quintana, F.J.3
-
132
-
-
33847609214
-
Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population
-
Li W, Minohara M, Su JJ et al.: Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J. Neuroimmunol. 184(1-2), 227-231 (2007).
-
(2007)
J. Neuroimmunol
, vol.184
, Issue.1-2
, pp. 227-231
-
-
Li, W.1
Minohara, M.2
Su, J.J.3
-
133
-
-
42749091150
-
Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis
-
Pezeshki MZ, Zarrintan S, Zarrintan MH: Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis. Med. Hypotheses 70(6), 1223 (2008).
-
(2008)
Med. Hypotheses
, vol.70
, Issue.6
, pp. 1223
-
-
Pezeshki, M.Z.1
Zarrintan, S.2
Zarrintan, M.H.3
-
134
-
-
64149123239
-
Immunosuppression in clinical practice: Approaches to individualized therapy
-
Chan A, Stuve O, von Ahsen N: Immunosuppression in clinical practice: approaches to individualized therapy. J. Neurol. 255(Suppl. 6), 22-27 (2008).
-
(2008)
J. Neurol
, vol.255
, Issue.SUPPL. 6
, pp. 22-27
-
-
Chan, A.1
Stuve, O.2
von Ahsen, N.3
-
136
-
-
38349186321
-
Intense immunosuppression in patients with rapidly worsening multiple sclerosis: Treatment guidelines for the clinician
-
Boster A, Edan G, Frohman E et al.: Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician. Lancet Neurol.. 7(2), 173-183 (2008).
-
(2008)
Lancet Neurol
, vol.7
, Issue.2
, pp. 173-183
-
-
Boster, A.1
Edan, G.2
Frohman, E.3
-
137
-
-
34250816184
-
Fullerene nanomaterials inhibit the allergic response
-
Ryan JJ, Bateman HR, Stover A et al.: Fullerene nanomaterials inhibit the allergic response. J. Immunol. 179(1), 665-672 (2007).
-
(2007)
J. Immunol
, vol.179
, Issue.1
, pp. 665-672
-
-
Ryan, J.J.1
Bateman, H.R.2
Stover, A.3
-
138
-
-
58549108776
-
Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease
-
van Kasteren SI, Campbell SJ, Serres S, Anthony DC, Sibson NR, Davis BG: Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc. Natl Acad. Sci. USA 106(1), 18-23 (2009).
-
(2009)
Proc. Natl Acad. Sci. USA
, vol.106
, Issue.1
, pp. 18-23
-
-
van Kasteren, S.I.1
Campbell, S.J.2
Serres, S.3
Anthony, D.C.4
Sibson, N.R.5
Davis, B.G.6
-
139
-
-
34948863876
-
In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide
-
McAteer MA, Sibson NR, von Zur Muhlen C et al.: In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat. Med. 13(10), 1253-1258 (2007).
-
(2007)
Nat. Med
, vol.13
, Issue.10
, pp. 1253-1258
-
-
McAteer, M.A.1
Sibson, N.R.2
von Zur3
Muhlen, C.4
-
140
-
-
34250773901
-
Magnetic resonance imaging of human, brain macrophage infiltration
-
Petry KG, Boiziau C, Dousset V, Brochet B: Magnetic resonance imaging of human, brain macrophage infiltration. Neurotherapeutics 4(3), 434-442 (2007).
-
(2007)
Neurotherapeutics
, vol.4
, Issue.3
, pp. 434-442
-
-
Petry, K.G.1
Boiziau, C.2
Dousset, V.3
Brochet, B.4
-
141
-
-
33749039453
-
Risk factors for ischemic stroke subtypes: The Atherosclerosis Risk in Communities study
-
Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH Jr, Folsom AR: Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke 37(10), 2493-2498 (2006).
-
(2006)
Stroke
, vol.37
, Issue.10
, pp. 2493-2498
-
-
Ohira, T.1
Shahar, E.2
Chambless, L.E.3
Rosamond, W.D.4
Mosley Jr, T.H.5
Folsom, A.R.6
-
142
-
-
68149160611
-
Nanoparticle-mediated delivery of superoxide dismutase to the brain: An effective strategy to reduce ischemia-reperfusion injury
-
Reddy MK, Labhasetwar V: Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J. 23(5), 1384-1395 (2009).
-
(2009)
FASEB J
, vol.23
, Issue.5
, pp. 1384-1395
-
-
Reddy, M.K.1
Labhasetwar, V.2
-
143
-
-
34250367839
-
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides
-
Chen J, Patil S, Seal S, McGinnis JF: Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat. Nanotechnol. 1(2), 142-150 (2006).
-
(2006)
Nat. Nanotechnol
, vol.1
, Issue.2
, pp. 142-150
-
-
Chen, J.1
Patil, S.2
Seal, S.3
McGinnis, J.F.4
-
144
-
-
32644468773
-
Cerium and yttrium oxide nanoparticles are neuroprotective
-
Schubert D, Dargusch R, Raitano J, Chan SW: Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem. Biophys. Res. Commun. 342(1), 86-91 (2006).
-
(2006)
Biochem. Biophys. Res. Commun
, vol.342
, Issue.1
, pp. 86-91
-
-
Schubert, D.1
Dargusch, R.2
Raitano, J.3
Chan, S.W.4
-
145
-
-
33846314024
-
Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons
-
Das M, Patil S, Bhargava N et al.: Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28(10), 1918-1925 (2007).
-
(2007)
Biomaterials
, vol.28
, Issue.10
, pp. 1918-1925
-
-
Das, M.1
Patil, S.2
Bhargava, N.3
-
146
-
-
0025162527
-
Liposome-encapsulated hemoglobin: An oxygen-carrying fluid
-
Rabinovici R, Rudolph AS, Ligler FS, Yue TL, Feuerstein G: Liposome-encapsulated hemoglobin: an oxygen-carrying fluid. Circ. Shock 32(1), 1-17 (1990).
-
(1990)
Circ. Shock
, vol.32
, Issue.1
, pp. 1-17
-
-
Rabinovici, R.1
Rudolph, A.S.2
Ligler, F.S.3
Yue, T.L.4
Feuerstein, G.5
-
147
-
-
34247563851
-
Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: Evaluation with photochemically induced thrombosis of the middle cerebral artery
-
Kawaguchi AT, Fukumoto D, Haida M, Ogata Y, Yamano M, Tsukada H: Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat: evaluation with photochemically induced thrombosis of the middle cerebral artery. Stroke 38(5), 1626-1632 (2007).
-
(2007)
Stroke
, vol.38
, Issue.5
, pp. 1626-1632
-
-
Kawaguchi, A.T.1
Fukumoto, D.2
Haida, M.3
Ogata, Y.4
Yamano, M.5
Tsukada, H.6
-
148
-
-
57749201812
-
Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in rats: Effect of oxygen affinity
-
Fukumoto D, Kawaguchi AT, Haida M, Yamano M, Ogata Y, Tsukada H: Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in rats: effect of oxygen affinity. Artif. Organs 33(2), 159-163 (2009).
-
(2009)
Artif. Organs
, vol.33
, Issue.2
, pp. 159-163
-
-
Fukumoto, D.1
Kawaguchi, A.T.2
Haida, M.3
Yamano, M.4
Ogata, Y.5
Tsukada, H.6
-
149
-
-
58849160970
-
Liposome-encapsulated hemoglobin alleviates brain edema after permanent occlusion of the middle cerebral artery in rats
-
Kawaguchi AT, Kurita D, Furuya H, Yamano M, Ogata Y, Haida M: Liposome-encapsulated hemoglobin alleviates brain edema after permanent occlusion of the middle cerebral artery in rats. Artif. Organs 33(2), 153-158 (2009).
-
(2009)
Artif. Organs
, vol.33
, Issue.2
, pp. 153-158
-
-
Kawaguchi, A.T.1
Kurita, D.2
Furuya, H.3
Yamano, M.4
Ogata, Y.5
Haida, M.6
-
150
-
-
57749185892
-
In vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomography
-
Urakami T, Kawaguchi AT, Akai S et al.: In vivo distribution of liposome-encapsulated hemoglobin determined by positron emission tomography. Artif. Organs 33(2), 164-168 (2009).
-
(2009)
Artif. Organs
, vol.33
, Issue.2
, pp. 164-168
-
-
Urakami, T.1
Kawaguchi, A.T.2
Akai, S.3
-
151
-
-
9644272621
-
HIV dementia: An evolving disease
-
McArthur JC: HIV dementia: an evolving disease. J. Neuroimmunol. 157(1-2), 3-10 (2004).
-
(2004)
J. Neuroimmunol
, vol.157
, Issue.1-2
, pp. 3-10
-
-
McArthur, J.C.1
-
152
-
-
33644845025
-
Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases
-
Kadiu I, Glanzer JG, Kipnis J, Gendelman HE, Thomas MP: Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases. Neurotox. Res. 8(1-2); 25-50 (2005).
-
(2005)
Neurotox. Res
, vol.8
, Issue.1-2
, pp. 25-50
-
-
Kadiu, I.1
Glanzer, J.G.2
Kipnis, J.3
Gendelman, H.E.4
Thomas, M.P.5
-
153
-
-
0025787561
-
Human immunodeficiency virus-1 infection of the nervous system: An autopsy study of 268 adult, pediatric, and fetal brains
-
Kure K, Llena JF, Lyman WD et al.: Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum. Pathol. 22(7), 700-710 (1991).
-
(1991)
Hum. Pathol
, vol.22
, Issue.7
, pp. 700-710
-
-
Kure, K.1
Llena, J.F.2
Lyman, W.D.3
-
154
-
-
0029126868
-
AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations
-
Brew BJ, Rosenblum M, Cronin K, Price RW: AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann. Neurol. 38(4), 563-570 (1995).
-
(1995)
Ann. Neurol
, vol.38
, Issue.4
, pp. 563-570
-
-
Brew, B.J.1
Rosenblum, M.2
Cronin, K.3
Price, R.W.4
-
155
-
-
22744455058
-
HIV-1 infection and AIDS: Consequences for the central nervous system
-
Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA: HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12(Suppl. 1), 878-892 (2005).
-
(2005)
Cell Death Differ
, vol.12
, Issue.SUPPL. 1
, pp. 878-892
-
-
Kaul, M.1
Zheng, J.2
Okamoto, S.3
Gendelman, H.E.4
Lipton, S.A.5
-
156
-
-
53849134844
-
Cellular reservoirs of HIV-1 and their role in viral persistence
-
Alexaki A, Liu Y, Wigdahl B: Cellular reservoirs of HIV-1 and their role in viral persistence. Curr. HIV Res. 6(5), 388-400 (2008).
-
(2008)
Curr. HIV Res
, vol.6
, Issue.5
, pp. 388-400
-
-
Alexaki, A.1
Liu, Y.2
Wigdahl, B.3
-
157
-
-
66749103433
-
The transport of anti-HIV drugs across blood-CNS interfaces: Summary of current knowledge and recommendations for further research
-
Varatharajan L, Thomas SA: The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res. 82(2), A99-A109 (2009).
-
(2009)
Antiviral Res
, vol.82
, Issue.2
-
-
Varatharajan, L.1
Thomas, S.A.2
-
158
-
-
68249144974
-
NanoART, NeuroAIDS and CNS drug delivery
-
Nowacek A, Gendelman HE: NanoART, NeuroAIDS and CNS drug delivery. Nanomedicine 4(5), 557-574 (2009).
-
(2009)
Nanomedicine
, vol.4
, Issue.5
, pp. 557-574
-
-
Nowacek, A.1
Gendelman, H.E.2
-
159
-
-
51749096415
-
Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line
-
Chattopadhyay N, Zastre J, Wong HL, Wu XY, Bendayan R: Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm. Res. 25(10), 2262-2271 (2008).
-
(2008)
Pharm. Res
, vol.25
, Issue.10
, pp. 2262-2271
-
-
Chattopadhyay, N.1
Zastre, J.2
Wong, H.L.3
Wu, X.Y.4
Bendayan, R.5
-
160
-
-
50849094554
-
TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
-
Rao KS, Reddy MK, Horning JL, Labhasetwar V: TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29(33), 4429-4438 (2008).
-
(2008)
Biomaterials
, vol.29
, Issue.33
, pp. 4429-4438
-
-
Rao, K.S.1
Reddy, M.K.2
Horning, J.L.3
Labhasetwar, V.4
-
161
-
-
34447268486
-
Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles
-
Kup YC, Su FL: Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int. J. Pharm. 340(1-2), 143-152 (2007).
-
(2007)
Int. J. Pharm
, vol.340
, Issue.1-2
, pp. 143-152
-
-
Kup, Y.C.1
Su, F.L.2
|